Robert G. Finizio, CEO at TherapeuticsMD, Inc. (TXMD), sold 135,394 shares at $1.04 ($141K) on 2021-05-11, disclosed to the SEC on 2021-05-12.
Open-market sale of $141k TXMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.04 | 67,697 | $70K | 50.0% |
| 2 | $1.04 | 67,697 | $70K | 50.0% |
| Total | $1.04 avg | 135,394 | $141K | 100% |
| Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |
| TXMD | BUY | 2019-08-12 | $310K | — | Filing → |